Get SOPHiA GENETICS alerts:Check Out Our Latest Analysis on SOPHiA GENETICSInsider Activity at SOPHiA GENETICSKey Headlines Impacting SOPHiA GENETICSIn other news, CEO Ross Muken sold 9,838 shares of SOPHiA GENETICS stock in a transaction dated Monday, July 6th. Negative Sentiment: Bottom-line miss: SOPHiA GENETICS reported a second-quarter loss of $0.26 per share, worse than the $0.21 consensus estimate. SOPHiA GENETICS had a negative return on equity of 62.74% and a negative net margin of 44.48%. On average, sell-side analysts predict that SOPHiA GENETICS SA will post -0.58 EPS for the current year. Further ReadingReceive News & Ratings for SOPHiA GENETICS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOPHiA GENETICS and related companies with MarketBeat.com's FREE daily email newsletter.